Terms: = Ovarian cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Staging
5 results:
1. Can mismatch repair status be added to sentinel lymph node mapping algorithm in endometrioid endometrial cancer?
Diniz TP; Menezes JN; Goncalves BT; Faloppa CC; Mantoan H; Kumagai LY; Badiglian-Filho L; Bovolim G; Guimaraes APG; De Brot L; Baiocchi G
Gynecol Oncol; 2023 Feb; 169():131-136. PubMed ID: 36580755
[TBL] [Abstract] [Full Text] [Related]
2. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
[TBL] [Abstract] [Full Text] [Related]
3. Microcystic, Elongated, and Fragmented Pattern Invasion in ovarian Endometrioid Carcinoma: Immunohistochemical Profile and Prognostic Implications.
Goldberg A; Hand L; DeCotiis D; Rosenblum N; Chan J
Int J Gynecol Pathol; 2018 Jan; 37(1):44-51. PubMed ID: 28319570
[TBL] [Abstract] [Full Text] [Related]
4. Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds.
Grindedal EM; Renkonen-Sinisalo L; Vasen H; Evans G; Sala P; Blanco I; Gronwald J; Apold J; Eccles DM; Sánchez AA; Sampson J; Järvinen HJ; Bertario L; Crawford GC; Stormorken AT; Maehle L; Moller P
J Med Genet; 2010 Feb; 47(2):99-102. PubMed ID: 19635727
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of hmlh1 and hMSH2 expression in cisplatin-treated ovarian cancer patients.
Magnowska M; Surowiak P; Nowak-Markwitz E; Michalak M; Magnowski P; Rokita W; Kedzia H; Zabel M; Spaczyński M
Ginekol Pol; 2008 Dec; 79(12):826-34. PubMed ID: 19175039
[TBL] [Abstract] [Full Text] [Related]
